Reporter Oct 10 2014
Oct. 9, 2014—Conventional therapy for patients diagnosed with retinoblastoma, the most common ocular cancer in children, includes systemic chemotherapy, external beam radiation and/or surgical removal of the eye. Doctors at Vanderbilt University Medical Center are on track to radically change the way the disease is treated using an emerging therapeutic approach called intra-arterial chemotherapy, or IA chemo.
Oct. 9, 2014—College athletes who play contact sports are more than twice as likely to carry the deadly superbug methicillin-resistant Staphylocuccus aureus (MRSA) than peers who play non-contact sports, according to a Vanderbilt study released at IDWeek 2014.
Oct. 9, 2014—Vanderbilt University Medical Center has been named a finalist for the NEXT Awards for its implementation of the Dragon voice-to-text software program. VUMC’s Workforce Performance Operations partnered with the Vanderbilt Medical Group Systems Engineering team to deploy the Dragon voice-to-text project to all 3,000-plus providers for a do-it-yourself (DIY) installation.
Oct. 9, 2014—Vanderbilt investigators have discovered a new type of immune cell residing in the intestinal epithelium that may function as a first line of defense against ingested pathogens.
Oct. 9, 2014—Vanderbilt Heart and Vascular Institute (VHVI) reached a significant milestone recently with the 100th implantation of the miniaturized HeartWare HVAD Pump, a left ventricular assist device (LVAD) that supports the heart.
Oct. 3, 2014—The Commodore Award, Vanderbilt’s highest staff honor, was presented to two staff members during the Service Awards Celebration Oct. 1 in Langford Auditorium.